BACKGROUND: Many factors have been identified that influence the recruitment of African Americans into clinical trials; however, the influence of eligibility criteria may not be widely appreciated. We used the experience from the Look AHEAD (Action for Health in Diabetes) trial screening process to examine the differential impact eligibility criteria had on the enrollment of African Americans compared to other volunteers. METHODS: Look AHEAD is a large randomized clinical trial to examine whether assignment to an intensive lifestyle intervention designed to produce and maintain weight loss reduces the long-term risk of major cardiovascular events in adults with type 2 diabetes. Differences in the screening, eligibility, and enrollment rates between African Americans and members of other racial/ethnic groups were examined to identify possible reasons. RESULTS: Look AHEAD screened 28,735 individuals for enrollment, including 6226 (21.7%) who were self-identified African Americans. Of these volunteers, 12.9% of the African Americans compared to 19.3% of all other screenees ultimately enrolled (p < 0.001). African Americans no more often than others were lost to follow-up or refused to attend clinic visits to establish eligibility. Furthermore, the enrollment rates of individuals with histories of cardiovascular disease and diabetes therapy did not markedly differ between the ethnic groups. Higher prevalence of adverse levels of blood pressure, heart rate, HbA1c, and serum creatinine among African American screenees accounted for the greater proportions excluded (all p < 0.001). CONCLUSIONS: Compared to non-African Americans, African American were more often ineligible for the Look AHEAD trial due to comorbid conditions. Monitoring trial eligibility criteria for differential impact, and modifying them when appropriate, may ensure greater enrollment yields.
RCT Entities:
BACKGROUND: Many factors have been identified that influence the recruitment of African Americans into clinical trials; however, the influence of eligibility criteria may not be widely appreciated. We used the experience from the Look AHEAD (Action for Health in Diabetes) trial screening process to examine the differential impact eligibility criteria had on the enrollment of African Americans compared to other volunteers. METHODS: Look AHEAD is a large randomized clinical trial to examine whether assignment to an intensive lifestyle intervention designed to produce and maintain weight loss reduces the long-term risk of major cardiovascular events in adults with type 2 diabetes. Differences in the screening, eligibility, and enrollment rates between African Americans and members of other racial/ethnic groups were examined to identify possible reasons. RESULTS: Look AHEAD screened 28,735 individuals for enrollment, including 6226 (21.7%) who were self-identified African Americans. Of these volunteers, 12.9% of the African Americans compared to 19.3% of all other screenees ultimately enrolled (p < 0.001). African Americans no more often than others were lost to follow-up or refused to attend clinic visits to establish eligibility. Furthermore, the enrollment rates of individuals with histories of cardiovascular disease and diabetes therapy did not markedly differ between the ethnic groups. Higher prevalence of adverse levels of blood pressure, heart rate, HbA1c, and serum creatinine among African American screenees accounted for the greater proportions excluded (all p < 0.001). CONCLUSIONS: Compared to non-African Americans, African American were more often ineligible for the Look AHEAD trial due to comorbid conditions. Monitoring trial eligibility criteria for differential impact, and modifying them when appropriate, may ensure greater enrollment yields.
Authors: Julienne K Kirk; Ralph B D'Agostino; Ronny A Bell; Leah V Passmore; Denise E Bonds; Andrew J Karter; K M Venkat Narayan Journal: Diabetes Care Date: 2006-09 Impact factor: 19.112
Authors: Grace L Smith; Michael G Shlipak; Edward P Havranek; Frederick A Masoudi; William M McClellan; JoAnne M Foody; Saif S Rathore; Harlan M Krumholz Journal: Circulation Date: 2005-03-15 Impact factor: 29.690
Authors: Eugene Z Oddone; Maren K Olsen; Jennifer Hoff Lindquist; Melinda Orr; Ronnie Horner; Domenic Reda; Philip Lavori; Gary Johnson; Joseph Collins; John R Feussner Journal: Control Clin Trials Date: 2004-08
Authors: Donna H Ryan; Mark A Espeland; Gary D Foster; Steven M Haffner; Van S Hubbard; Karen C Johnson; Steven E Kahn; William C Knowler; Susan Z Yanovski Journal: Control Clin Trials Date: 2003-10
Authors: Lucile L Adams-Campbell; Chiledum Ahaghotu; Melvin Gaskins; Fitzroy W Dawkins; Duane Smoot; Octavius D Polk; Robert Gooding; Robert L DeWitty Journal: J Clin Oncol Date: 2004-02-15 Impact factor: 44.544
Authors: Mark A Espeland; Sarah A Gaussoin; Judy Bahnson; Elizabeth M Vaughan; William C Knowler; Felicia R Simpson; Helen P Hazuda; Karen C Johnson; Medha N Munshi; Mace Coday; Xavier Pi-Sunyer Journal: J Am Geriatr Soc Date: 2020-07-17 Impact factor: 5.562
Authors: Delia Smith West; Gareth Dutton; Linda M Delahanty; Helen P Hazuda; Amy D Rickman; William C Knowler; Mara Z Vitolins; Rebecca H Neiberg; Anne Peters; Molly Gee; Maria Cassidy Begay Journal: Obesity (Silver Spring) Date: 2019-08 Impact factor: 5.002
Authors: Valery S Effoe; Jeffrey A Katula; Julienne K Kirk; Carolyn F Pedley; Linda Y Bollhalter; W Mark Brown; Margaret R Savoca; Stedman T Jones; Janet Baek; Alain G Bertoni Journal: Trials Date: 2016-10-13 Impact factor: 2.279
Authors: Christopher P Dwyer; Helen McAneney; Fionnuala M Rogers; Robert Joyce; Sinéad M Hynes Journal: BMC Med Res Methodol Date: 2021-11-27 Impact factor: 4.615
Authors: Mace Coday; Phyllis Richey; Fridtjof Thomas; Quynh T Tran; Sarah B Terrell; Fran Tylavsky; Danielle Miro; Margaret Caufield; Karen C Johnson Journal: Contemp Clin Trials Commun Date: 2016-04-15
Authors: Eliza G Miller; Caryl A Nowson; David W Dunstan; Deborah A Kerr; Vicky Solah; David Menzies; Robin M Daly Journal: Trials Date: 2016-09-26 Impact factor: 2.279